SMMT
Summit Therapeutics Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +30.0% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 86 | +5 | 84.29M | $1.23B | +8 | −2 |
| Q1 2026 | 82 | +1 | 68.40M | $1.29B | +10 | −10 |
| Q4 2025 | 81 | 0 | 72.69M | $1.27B | +1 | — |
| Q3 2025 | 15 | -1 | 45.07M | $931.26M | +1 | −3 |
| Q2 2025 | 14 | 0 | 38.14M | $811.62M | +1 | −1 |
| Q1 2025 | 11 | +1 | 18.29M | $352.78M | +1 | — |
| Q4 2024 | 10 | +1 | 17.85M | $318.58M | +1 | — |
| Q3 2024 | 8 | 0 | 10.94M | $239.67M | +1 | −1 |
| Q2 2024 | 8 | — | 7.47M | $58.27M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 5.44M | +166.4% | $119.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 5.44M | +166.4% | $119.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 3.10M | +4.6% | $67.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 3.10M | +4.6% | $67.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.22M | -37.1% | $26.77M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 650.83K | Nieuw | $14.25M | 0.0% | New | 1 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 402.17K | +1254.1% | $8.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 68.52K | +10.3% | $1.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 68.52K | +10.3% | $1.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 44.19K | -83.5% | $967,718 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 44.19K | -83.5% | $967,718 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 44.19K | -83.5% | $967,718 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 44.19K | -83.5% | $967,718 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 15.91K | -18.4% | $348,385 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Citadel Advisors | $14.25M | 0.0% |
Verlaten
| Arrowstreet Capital | $1.10M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 223 houders, 118.88M aandelen, $2.10B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.